Cargando…

PEPT1-mediated prodrug strategy for oral delivery of peramivir

Peramivir was a novel and highly potent neuraminidase (NA) inhibitor for the treatment of influenza A and B. However, it exhibited a very low oral bioavailability (only 3%) due to the high polarity (log P of −1.4) and the low membrane permeability across the intestine. To utilize the PEPT1-mediated...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sun, Yongbing, Gan, Wei, Lei, Mingdao, Jiang, Wei, Cheng, Meng, He, Junwei, Sun, Qi, Liu, Wan, Hu, Lvjiang, Jin, Yi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Shenyang Pharmaceutical University 2018
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7032255/ https://www.ncbi.nlm.nih.gov/pubmed/32104429 http://dx.doi.org/10.1016/j.ajps.2018.05.008

Ejemplares similares

Dipeptide-modified nanoparticles to facilitate oral docetaxel delivery: new insights into PepT1-mediated targeting strategy
por: Du, Yuqian, et al.
Publicado: (2018)

Peramivir for influenza
Publicado: (2019)

Enhanced Absorption and Growth Inhibition with Amino Acid Monoester Prodrugs of Floxuridine by Targeting hPEPT1 Transporters
por: Tsume, Yasuhiro, et al.
Publicado: (2008)

USP18 Sensitivity of Peptide Transporters PEPT1 and PEPT2
por: Warsi, Jamshed, et al.
Publicado: (2015)

Cryo-EM structure of PepT2 reveals structural basis for proton-coupled peptide and prodrug transport in mammals
por: Parker, Joanne L., et al.
Publicado: (2021)

Safety and efficacy of peramivir for influenza treatment
por: Hata, Atsuko, et al.
Publicado: (2014)

Oseltamivir/peramivir: Lack of efficacy: case report
Publicado: (2020)

Standard method for performing positron emission particle tracking (PEPT) measurements of froth flotation at PEPT Cape Town
por: Cole, Katie, et al.
Publicado: (2022)

Peptide transporter structure reveals binding and action mechanism of a potent PEPT1 and PEPT2 inhibitor
por: Stauffer, Mirko, et al.
Publicado: (2022)

Peramivir, an Anti-Influenza Virus Drug, Exhibits Potential Anti-Cytokine Storm Effects
por: Zhang, Chen-xi, et al.
Publicado: (2022)

Crystal Structures of the Extracellular Domain from PepT1 and PepT2 Provide Novel Insights into Mammalian Peptide Transport
por: Beale, John H., et al.
Publicado: (2015)

Critical Role of PepT1 in Promoting Colitis-Associated Cancer and Therapeutic Benefits of the Anti-inflammatory PepT1-Mediated Tripeptide KPV in a Murine Model
por: Viennois, Emilie, et al.
Publicado: (2016)

Comparison of Efficacy of Intravenous Peramivir and Oral Oseltamivir for the Treatment of Influenza: Systematic Review and Meta-Analysis
por: Lee, Jonghoo, et al.
Publicado: (2017)

Structural snapshots of human PepT1 and PepT2 reveal mechanistic insights into substrate and drug transport across epithelial membranes
por: Killer, Maxime, et al.
Publicado: (2021)

A Case of Influenza Associated Fulminant Myocarditis Successfully Treated with Intravenous Peramivir
por: Baik, Seung Hee, et al.
Publicado: (2015)

Peramivir and laninamivir susceptibility of circulating influenza A and B viruses
por: Leang, Sook-Kwan, et al.
Publicado: (2014)

Peramivir injection in the treatment of acute influenza: a review of the literature
por: Wester, Ashley, et al.
Publicado: (2016)

Modern Prodrug Design for Targeted Oral Drug Delivery
por: Dahan, Arik, et al.
Publicado: (2014)

Prodrug Strategies for Paclitaxel
por: Meng, Ziyuan, et al.
Publicado: (2016)

Single Dose IV Peramivir is Safe and Effective in the Treatment of Pediatric Influenza
por: Vanchiere, John, et al.
Publicado: (2017)

A Meta-Analysis Comparing the Efficacy and Safety of Peramivir with Other Neuraminidase Inhibitors for Influenza Treatment
por: Chen, Jui-Yi, et al.
Publicado: (2020)

Regulation profile of the intestinal peptide transporter 1 (PepT1)
por: Wang, Chun-Yang, et al.
Publicado: (2017)

A Retrospective Analysis of Three Antiviral Regimens of Peramivir in the Treatment of Severe Influenza A with Primary Viral Pneumonia
por: Wang, Jin-na, et al.
Publicado: (2019)

Epigenetic regulation of intestinal peptide transporter PEPT1 as a potential strategy for colorectal cancer sensitization
por: Wang, Yanhong, et al.
Publicado: (2021)

Clinical Effectiveness of Peramivir in Comparison with Other Neuraminidase Inhibitors in Pediatric Influenza Patients
por: Hikita, Toshiyuki, et al.
Publicado: (2012)

Peramivir: A Novel Intravenous Neuraminidase Inhibitor for Treatment of Acute Influenza Infections
por: Alame, Malak M., et al.
Publicado: (2016)

Clinical Effectiveness and Safety of Peramivir for Influenza Infection: Safe and Effective Antiviral Treatment
por: Lee, Jin Seo
Publicado: (2018)

Pathogenicity and peramivir efficacy in immunocompromised murine models of influenza B virus infection
por: Pascua, Philippe Noriel Q., et al.
Publicado: (2017)

Clinical Effectiveness of Intravenous Peramivir versus Oseltamivir for the Treatment of Influenza in Hospitalized Patients
por: Lee, Jin Seo, et al.
Publicado: (2020)

Evaluation of Baloxavir Marboxil and Peramivir for the Treatment of High Pathogenicity Avian Influenza in Chickens
por: Twabela, Augustin, et al.
Publicado: (2020)

Tetrazine-mediated bioorthogonal prodrug–prodrug activation
por: Neumann, Kevin, et al.
Publicado: (2018)

Physiological and therapeutic regulation of glucose homeostasis by upper small intestinal PepT1-mediated protein sensing
por: Dranse, Helen J., et al.
Publicado: (2018)

JAK2 Mediates the Regulation of Pept1 Expression by Leptin in the Grass Carp (Ctenopharyngodon idella) Intestine
por: Luo, Wen-jie, et al.
Publicado: (2020)

Targeting PEPT1: a novel strategy to improve the antitumor efficacy of doxorubicin in human hepatocellular carcinoma therapy
por: Gong, Yanxia, et al.
Publicado: (2017)

Butyrate Transcriptionally Enhances Peptide Transporter PepT1 Expression and Activity
por: Dalmasso, Guillaume, et al.
Publicado: (2008)

PeptX: Using Genetic Algorithms to optimize peptides for MHC binding
por: Knapp, Bernhard, et al.
Publicado: (2011)

Structural basis for oligomerization of the prokaryotic peptide transporter PepT(So2)
por: Nagamura, Reina, et al.
Publicado: (2019)

Cancer Cell‐Specific Fluorescent Prodrug Delivery Platforms
por: Ma, Siyue, et al.
Publicado: (2023)

Oral liposomal delivery of an activatable budesonide prodrug reduces colitis in experimental mice
por: Xian, Shiyun, et al.
Publicado: (2023)

Molecular Insights to the Structure-Interaction Relationships of Human Proton-Coupled Oligopeptide Transporters (PepTs)
por: Luo, Yining, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_1to3ao2884eprqa30s5cjdcnbb